Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RPE65-mediated retinal dystrophy
RPE65-mediated retinal dystrophy
How much is your vision worth? Spark CEO Jeff Marrazzo has a price in mind
Endpoints
Wed, 11/8/17 - 09:21 am
Spark Therapeutics
Jeff Marrazzo
gene therapy
RPE65-mediated retinal dystrophy
drug pricing
